Proficio Capital Partners LLC Acadia Pharmaceuticals Inc Transaction History

Proficio Capital Partners LLC

9 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 Apr 19, 2023	BUY	$16.32 - $20.92 $186,439 - $238,990	11,424 New	11,424 $214,000
Q3 2019 Nov 13, 2019	SELL	$22.22 - $44.01 $5,621 - $11,134	-253 Closed	0 $0
Q1 2019 May 13, 2019	BUY	$16.17 - $27.38 $3,282 - $5,558	203 Added 406.0%	253 $7,000
Q4 2018 Feb 08, 2019	BUY	$14.32 - $22.92 $716 - $1,146	50 New	50 $1,000
Q3 2018 Nov 13, 2018	SELL	$13.03 - $21.81 $208 - $348	-16 Closed	0 $0
Q2 2018 Aug 10, 2018	SELL	$15.07 - $22.34 $3,872 - $5,741	-257 Reduced 94.14%	16 $0
Q1 2018 May 14, 2018	BUY	$22.47 - $32.33 $1,415 - $2,036	63 Added 30.0%	273 $6,000
Q4 2017 Feb 09, 2018	BUY	$26.84 - $39.14 $4,616 - $6,732	172 Added 452.63%	210 $6,000
Q3 2017 Nov 14, 2017	BUY	$29.49 - $38.37 $1,120 - $1,458	38	38 $1,000

280

156M

901K

314K

Ticker ACAD
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 161,843,008
Market Cap $2.63B
Description
ACADIA Pharmaceuticals Inc., a biopharmaceutical company, focuses on the development and commercialization of small molecule drugs that address unmet medical needs in central nervous system disorders. The company offers NUPLAZID (pimavanserin) for the treatment of hallucinations and delusions associated with Parkinson's disease psychosis. It's p...

Get notified when there are updates to the investment portfolio of Proficio Capital Partners LLC, based on Form 13F filings with the SEC.

Stay updated on Proficio Capital Partners LLC with notifications on news.